Patient with a heterozygous pathogenic variant in CSNK2A1 gene: A new case to update the Okur–Chung neurodevelopmental syndrome
American Journal of Medical Genetics Part A · 2024-09 · 194 (9)
DOI: 10.1002/ajmg.a.63642 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 06.05.2024. Verfasst von Albin Blanc und 16 weiteren Autor:innen. Beteiligte Einrichtung: Service de génétique clinique, CHRU de Nancy, Nancy, France. Hauptthemen laut MEDLINE: Casein Kinase II, Neurodevelopmental Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The autosomal dominant Okur–Chung neurodevelopmental syndrome (OCNDS: OMIM #617062) is a rare neurodevelopmental disorder first described in 2016. Features include developmental delay (DD), intellectual disability (ID), behavioral problems, hypotonia, language deficits, congenital heart abnormalities, and non‐specific dysmorphic facial features. OCNDS is caused by heterozygous pathogenic variants in CSNK2A1 (OMIM *115440; NM_177559.3). To date, 160 patients have been diagnosed worldwide. The number will likely increase due to the growing use of exome sequencing (ES) and genome sequencing (GS). Here, we describe a novel OCNDS patient carrying a CSNK2A1 variant (NM_177559.3:c.140G>A; NP_808227.1:p.Arg47Gln). Phenotypically, he presented with DD, ID, generalized hypotonia, speech delay, short stature, microcephaly, and dysmorphic features such as low‐set ears, hypertelorism, thin upper lip, and a round face. The patient showed several signs not yet described that may extend the phenotypic spectrum of OCNDS. These include prenatal bilateral clubfeet, exotropia, and peg lateral incisors. However, unlike the majority of descriptions, he did not present sleep disturbance, seizures or gait difficulties. A literature review shows phenotypic heterogeneity for OCNDS, whether these patients have the same variant or not. This case report is an opportunity to refine the phenotype of this syndrome and raise the question of the genotype–phenotype correlation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service de génétique clinique, CHRU de Nancy, Nancy, France.
- Laboratoire de génétique médicale, CHRU Nancy, Nancy, France.
- Université de Lorraine, INSERM UMR_S1256, NGERE, Nancy, France.
- Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.
- Université de Bourgogne, INSERM UMR_1231 GAD, Dijon, France.
- Service de Chirurgie orthopédique infantile, CHRU Nancy, Nancy, France.
ORCID-Profile: Albin Blanc, Céline Bonnet
Zitieren
APA
Blanc, A., Bonnet, C., Wandzel, M., Roth, V., Duffourd, Y., Safraou, H., Leheup, B., Muller, F., D Colne, J., Feillet, F., Schmitt, E., Castro, M., Savatt, J., Burcheri, A., Nemos, C., Philippe, C., & Lambert, L. (2024). Patient with a heterozygous pathogenic variant in CSNK2A1 gene: A new case to update the Okur–Chung neurodevelopmental syndrome. American Journal of Medical Genetics Part A, 194(9). https://doi.org/10.1002/ajmg.a.63642
Vancouver
Blanc A, Bonnet C, Wandzel M, Roth V, Duffourd Y, Safraou H, et al. Patient with a heterozygous pathogenic variant in CSNK2A1 gene: A new case to update the Okur–Chung neurodevelopmental syndrome. American Journal of Medical Genetics Part A. 2024;194(9). doi:10.1002/ajmg.a.63642
BibTeX
@article{Blanc2024,
author = {Blanc, Albin and Bonnet, Céline and Wandzel, Marion and Roth, Virginie and Duffourd, Yannis and Safraou, Hanna and Leheup, Bruno and Muller, Florence and D Colne, Julie and Feillet, François and Schmitt, Emmanuelle and Castro, Matheus and Savatt, Jullian and Burcheri, Adriano and Nemos, Christophe and Philippe, Christophe and Lambert, Laëtitia},
title = {Patient with a heterozygous pathogenic variant in CSNK2A1 gene: A new case to update the Okur–Chung neurodevelopmental syndrome},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
volume = {194},
number = {9},
doi = {10.1002/ajmg.a.63642}
}
EUVIMED